Pokeweed antiviral protein down-regulates Wnt/β-catenin signalling to attenuate liver fibrogenesis in vitro and in vivo

Digestive and Liver Disease

Volumn 43, Issue 7, 2011, Pages 559-566

  Li, Wenting ^a   Zhu, Chuanlong ^a   Chen, Xiliu ^b   Li, Yi ^a   Gao, Rentao ^a   Wu, Quan ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Hepatic fibrosis; Hepatic stellate cell; PAP; Wnt catenin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; CARBON TETRACHLORIDE; EOSIN; HEMATOXYLIN; HYALURONIC ACID; HYDROXYPROLINE; LAMININ; POKEWEED ANTIVIRUS PROTEIN; SMAD3 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FIBROGENESIS; HISTOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER DEVELOPMENT; LIVER FIBROSIS; LIVER FUNCTION; MALE; NONHUMAN; PATHOLOGY; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SERUM; SIGNAL TRANSDUCTION; STELLATE CELL;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DOWN-REGULATION; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MICROSCOPY, FLUORESCENCE; POLYMERASE CHAIN REACTION; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, WISTAR; RIBOSOME INACTIVATING PROTEINS, TYPE 1; RNA; WNT SIGNALING PATHWAY;

EID: 79957623773     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.02.016     Document Type: Article

References (31)

1. Friedman S.L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000, 275:2247-2250.
2. Jiang F., Parsons C.J., Stefanovic B. Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. J Hepatol 2006, 45:401-409.
3. Jiao J., Friedman S.L., Aloman C. Hepatic fibrosis. Curr Opin Gastroenterol 2009, 25:223-229.
4. Nejak-Bowen K., Monga S.P. Wnt/β-catenin signaling in hepatic organogenesis. Organogenesis 2008, 4:92-99.
5. Xiong S.D., Yu K., Liu X.H., et al. Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells. Int J Cancer 2009, 125:774-782.
6. Kurinov I.V., Uckun F.M. High resolution X-ray structure of potent anti-HIV pokeweed antiviral protein-III. Biochem Pharmacol 2003, 65:1709-1717.
7. He Y.W., Guo C.X., Pan Y.F., et al. Inhibition of hepatitis B virus replication by pokeweed antiviral protein in vitro. World J Gastroenterol 2008, 14:1592-1597.
8. Zhu C., Sun Y., Luo X., et al. Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. Hum Gene Ther 2006, 17:589-600.
9. Yao X., Abrieu A., Zheng Y., Sullivan K.F., Cleveland D.W. CENP-E forms a link between attachment of spindle microtubules to kinetochores and the mitotic checkpoint. Nat Cell Biol 2000, 2000:484-491.
10. Fu K., Ahmed H., Ding X., et al. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Oncogene 2005, 24:5401-5413.
11. D'Argenio G., Amoruso D.C., Mazzone G., et al. Garlic extract prevents CCl(4)-induced liver fibrosis in rats: the role of tissue transglutaminase. Dig Liver Dis 2010, 42:571-577.
12. Vogel S., Piantedosi R., Frank J., et al. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res 2000, 41:882-893.
13. Friedman S.L. Hepatic fibrosis - overview. Toxicology 2008, 254:120-129.
14. Connolly M.K., Bedrosian A.S., Mallen-St Clair J., et al. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J Clin Invest 2009, 119:3213-3225.
15. Friedman S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008, 134:1655-1669.
16. Wu L.M., Wu X.X., Sun Y., et al. A novel synthetic oleanolic acid derivative (CPU-II2) attenuates liver fibrosis in mice through regulating the function of hepatic stellate cells. J Biomed Sci 2008, 15:251-259.
17. Al-Dosari M.S., Knapp J.E., Liu D. Hydrodynamic delivery. Adv Genet 2005, 54:65-82.
18. Lin C.C., Ezzelarab M., Hara H., et al. Atorvastatin or transgenic expression of TFPI inhibits coagulation initiated by anti-nonGal IgG binding to porcine aortic endothelial cells. J Thromb Haemost 2010, 8:2001-2010.
19. Nie Q.H., Zhu C.L., Zhang Y.F., et al. Inhibitory effect of antisense oligonucleotide targeting TIMP-2 on immune-induced liver fibrosis. Dig Dis Sci 2010, 55:1286-1295.
20. Hayasaka A., Saisho H. Serum markers as tools to monitor liver fibrosis. Digestion 1998, 59:381-384.
21. Körner T., Kropf J., Gressner A.M. Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value. J Hepatol 1996, 25:684-688.
22. Tangkijvanich P., Kongtawelert P., Pothacharoen P., et al. Serum hyaluronan: a marker of liver fibrosis in patients with chronic liver disease. Asian Pac J Allergy Immunol 2003, 21:115-120.
23. Rao H.Y., Wei L., Li J., et al. Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response. Hepatogastroenterology 2009, 56:328-334.
24. Yoshiji H., Kuriyama S., Miyamoto Y., et al. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 2000, 32:1248-1254.
25. Yoshiji H., Kuriyama S., Yoshii J., et al. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology 2002, 36:850-860.
26. Schiavon F. Transient joint effusion: a forgotten side effect of high dose corticosteroid treatment. Ann Rheum Dis 2003, 62:491-492.
27. Dvorak Z., Ulrichova J., Pichard-Garcia L., et al. Comparative effect of colchicine and colchiceine on cytotoxicity and CYP gene expression in primary human hepatocytes. Toxicol In Vitro 2002, 16:219-227.
28. Medici D., Hay E.D., Olsen B.R. Snail and slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Mol Biol Cell 2008, 19:4875-4887.
29. Wang Y., Sun Z., Qiu X., et al. Roles of Wnt/beta-catenin signaling in epithelial differentiation of mesenchymal stem cells. Biochem Biophys Res Commun 2009, 390:1309-1314.
30. Zhang M., Wang M., Tan X., et al. Smad3 prevents beta-catenin degradation and facilitates beta-catenin nuclear translocation in chondrocytes. J Biol Chem 2010, 285:8703-8710.
31. Li T.F., Chen D., Wu Q., et al. Transforming growth factor-beta stimulates cyclin D1 expression through activation of beta-catenin signaling in chondrocytes. J Biol Chem 2006, 281:21296-21304.